drugset / Trial / NCT02622659

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

NCT02622659

Phase 4 Completed 468 enrolled Guangzhou Yipinhong Pharmaceutical CO.,LTD
RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized, double blind, double dummy, positive drug parallel comparison, multi-centre clinical trial to assess the efficacy and safety of Fuganlin Oral Liquid in children with influenza (acute upper respiratory infection).

Timeline

Start
2012-03
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Fuganlin Oral Liquid Unknown 5 ml Oral
Subject Fuganlin Oral Liquid Unknown 10 ml Oral
Comparator Xiaoer Jiebiao Oral Liquid Unknown 5 ml Oral
Comparator Xiaoer Jiebiao Oral Liquid Unknown 10 ml Oral